MedTrace Logo

Cognitive Impact of Pomegranate Polyphenols Following Ischemic Stroke

NCT02442804 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-08-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether pomegranate supplements improve cognitive functioning following stroke.

Conditions

Interventions

DIETARY_SUPPLEMENT

POMx

Pomegranate supplement (1g) by mouth twice per day for 7 days

OTHER

Placebo

Placebo (for POMx, containing no antioxidant contents; 1g) capsule by mouth twice per day for 7 days

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02442804 on ClinicalTrials.gov